New Key Statistics Module, Z-Score and F-Score
AMEX:AIM Key Ratios
| Market Cap $ M | 18.56 |
| Enterprise Value $ M | 11.66 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.41 |
| Price/Sales | 90.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.64 |
| Beneish M-Score | -8.74 |
| 10-y EBITDA Growth Rate % | 43.10 |
| 5-y EBITDA Growth Rate % | 40.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.36 |
| EV-to-EBITDA | -0.36 |
| PEG | -- |
| Shares Outstanding M | 51.28 |
| Net Margin (%) | -16,123.32 |
| Operating Margin % | -17,282.90 |
| Pre-tax Margin (%) | -16,123.32 |
| Quick Ratio | 1.14 |
| Current Ratio | 1.14 |
| ROA % (ttm) | -115.67 |
| ROE % (ttm) | -151.37 |
| ROIC % (ttm) | -596.18 |
| Dividend Yield % | -- |
| Altman Z-Score | -41.15 |
AIM Number of Guru Trades
AIM Volume of Guru Trades
Gurus Latest Trades with AMEX:AIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:AIM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AIM ImmunoTech Inc Insider Transactions
No Available Data
News about AMEX:AIM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers